Clinicians can bill Category 1 CPT Code 75580 for adjunctive use of the artificial intelligence (AI)-powered Cleerly Ischemia software for fractional flow reserve estimates based on coronary computed tomography angiography (CCTA) scans.
A new Category 1 CPT code may enhance reimbursement for the use of adjunctive artificial intelligence (AI)-enabled software to ascertain fractional flow reserve (FFR) estimates in cases of suspected coronary artery disease (CAD).
The Cleerly Ischemia software (Cleerly), which can now be billed with the Category 1 CPT code 75580, allows non-invasive lesion mapping for findings of CAD, according to Cleerly, the develop of the Cleerly Ischemia software.
“The Cleerly Ischemia software provides noninvasive estimates of FFR values that help healthcare professionals make critical decisions in the management of patients with suspected coronary artery disease,” noted James P. Earls, M.D, the chief medical officer of Cleerly. “Cleerly Ischemia was purposely designed to output estimates of FFR values that are guideline-recommended by professional societies, and to allow comprehensive mapping of both anatomic and physiologic data for each and every coronary lesion across the entire vascular tree.”
Cleerly noted the new Category 1 CPT code is an addition to previously established Category III CPT codes for billing of the company’s advanced coronary atherosclerosis analysis.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.